A 58-year-old man presents with progressive memory loss and behavioral changes over 10 months. MRI shows asymmetric frontotemporal atrophy. What is the most appropriate symptomatic treatment?
A 53-year-old woman presents with progressive memory loss and personality changes over 8 months. MRI shows frontotemporal atrophy. CSF shows elevated tau but normal amyloid-β42. What is the most likely diagnosis?
A 59-year-old man presents with progressive memory loss and behavioral changes. MRI shows frontotemporal atrophy. What is the most likely diagnosis?
A 68-year-old man presents with progressive memory loss and parkinsonism. He has visual hallucinations and fluctuating cognition. What is the most likely diagnosis?
A 70-year-old man presents with confusion, agitation, and visual hallucinations that fluctuate throughout the day. He has a shuffling gait and mild tremor. His daughter reports he often falls asleep during conversations. What is the most likely diagnosis?
A 60-year-old man presents with progressive memory loss and behavioral changes over 8 months. MRI shows frontotemporal atrophy. What is the most likely diagnosis?
A 78-year-old man presents with confusion and falls. His wife reports he has been increasingly forgetful over the past year. MMSE score is 18/30. What is the most appropriate initial investigation?
A 27-year-old woman presents with amenorrhea, weight loss, and excessive exercise. She has fine lanugo hair and her BMI is 16 kg/m². She denies having an eating disorder. What is the most likely diagnosis?
A 52-year-old woman presents with progressive memory loss and personality changes over 8 months. MRI shows frontotemporal atrophy. CSF shows elevated tau but normal amyloid-β. What is the most likely diagnosis?
A 68-year-old man presents with progressive memory loss and behavioral changes. He has difficulty with language and shows disinhibited behavior. MRI shows frontotemporal atrophy. What is the most likely diagnosis?
Explanation: ***Supportive care only*** - Frontotemporal dementia (FTD), characterized by **progressive memory loss**, **behavioral changes**, and **asymmetric frontotemporal atrophy** on MRI, currently lacks disease-modifying treatments. - Management focuses on **supportive care**, including symptom management for agitation, sleep disturbances, and nutritional needs, alongside comprehensive caregiver support. *Cholinesterase inhibitors* - These medications, like donepezil or rivastigmine, are primarily used in **Alzheimer's disease** to enhance cholinergic neurotransmission. - They are generally **ineffective** in FTD and can potentially worsen behavioral symptoms in some patients. *Memantine* - Memantine is an **NMDA receptor antagonist** approved for moderate to severe **Alzheimer's disease**. - Its efficacy in FTD has **not been established**, and it is typically not recommended as a primary symptomatic treatment. *Antipsychotics for behavior* - While **antipsychotics** can be used cautiously to manage severe behavioral disturbances like aggression or psychosis in FTD, they are not a primary symptomatic treatment for the core disease process. - Their use carries **significant risks**, including increased mortality in elderly dementia patients, and should be reserved for severe, refractory symptoms. *Antidepressants* - **Antidepressants** may be used to address co-occurring **mood symptoms** such as depression or anxiety, which can be present in FTD. - They do not directly treat the core cognitive or behavioral aspects of FTD and are not considered a primary symptomatic treatment for the dementia itself.
Explanation: ***Frontotemporal dementia***- The clinical presentation of progressive **personality changes** and prominent **frontotemporal atrophy** on MRI is highly specific for FTD, particularly the behavioral variant (bvFTD).- The CSF profile of **elevated tau** with **normal amyloid-β42** is consistent with FTD, as amyloid-β42 is typically normal, unlike in Alzheimer's disease.*Alzheimer's disease*- AD typically begins with profound **episodic memory loss**, and early atrophy is usually centered in the **medial temporal lobes** (hippocampi), not primarily frontotemporal.- The CSF profile for established AD usually shows **low amyloid-β42** (due to amyloid plaque deposition) and high tau/phospho-tau; this patient's *normal* amyloid-β42 makes typical AD pathology less likely.*Lewy body dementia*- This diagnosis requires at least two of the following core features: **fluctuating cognition**, recurrent detailed **visual hallucinations**, or spontaneous **parkinsonism**, none of which are detailed here.- While atrophy can occur, profound frontotemporal atrophy and primary personality change are less characteristic of LBD compared to FTD.*Vascular dementia*- Vascular dementia is strongly associated with cerebrovascular risk factors and typically demonstrates **stepwise decline** or imaging evidence of multiple **infarcts** or extensive white matter disease.- The smooth progression over 8 months, coupled with atrophy focused specifically on the frontal lobes rather than diffuse vascular damage, argues against this diagnosis.*Creutzfeldt-Jakob disease*- CJD usually presents with very **rapid progression** (weeks to a few months) leading quickly to death, often accompanied by **myoclonus** (involuntary jerking).- Although CJD can present atypically, the 8-month course is too protracted for classic CJD, and the lack of characteristic MRI findings (e.g., DWI hyperintensities) makes it improbable.
Explanation: ***Frontotemporal dementia***- This diagnosis is strongly supported by the combination of **behavioral changes** (often presenting as apathy or disinhibition) and the specific radiographic finding of predominant **frontotemporal atrophy** on MRI.- FTD typically affects individuals under 65 (like this 59-year-old man) and is characterized by early decline in **personality**, social conduct, or **language abilities**, often before severe memory impairment.*Alzheimer's disease*- While memory loss is present, AD typically presents with early and predominant decline in **episodic memory** (new learning and recalling recent events).- The classic MRI finding in AD is atrophy primarily affecting the **medial temporal lobes** and **hippocampi**, not the anterior frontal and temporal lobes.*Vascular dementia*- This condition is typically associated with a history of **cerebrovascular disease** and imaging evidence of **multiple infarcts** or significant **ischemic white matter lesions**.- The course of decline is often abrupt or **stepwise**, corresponding to specific vascular events, rather than the gradual, smooth progression seen in primary neurodegenerative diseases.*Lewy body dementia*- Core features differentiating LBD include recurrent **well-formed visual hallucinations**, profound **fluctuations** in attention and alertness, and spontaneous **Parkinsonism**.- While memory and behavior are affected, the absence of these three hallmark symptoms makes **Lewy body dementia** less likely than FTD given the frontotemporal atrophy.*Normal pressure hydrocephalus*- NPH is characterized by the classic triad of **gait disturbance** (ataxia), **urinary incontinence**, and dementia, which is not fully described here.- MRI shows **ventriculomegaly** (enlarged ventricles) with often minimal or normal sulcal atrophy, a distinct finding from localized cortical atrophy.
Explanation: ***Lewy body dementia*** - The classic triad of **progressive memory loss** (dementia), **parkinsonism**, and **recurrent visual hallucinations**, along with **fluctuating cognition**, are hallmark diagnostic features of Lewy body dementia. - This condition is characterized by the presence of **Lewy bodies** in the brainstem and cortex, leading to a combination of cognitive and motor symptoms. *Alzheimer's disease* - While memory loss is prominent, **Alzheimer's disease** typically does not present with early or significant **parkinsonism** or prominent **visual hallucinations**. - Cognitive fluctuations are also not a primary distinguishing feature of Alzheimer's, which is more characterized by a gradual, progressive decline in memory and other cognitive domains. *Parkinson's disease dementia* - In **Parkinson's disease dementia (PDD)**, the **dementia** typically develops at least **one year after** the onset of well-established **parkinsonism**. - Although PDD can also feature visual hallucinations and cognitive fluctuations, the **temporal relationship** (parkinsonism preceding dementia by a significant period) is crucial for its diagnosis, unlike in LBD where symptoms often emerge concurrently or dementia precedes parkinsonism by less than a year. *Vascular dementia* - This condition is characterized by a **step-wise cognitive decline**, often associated with a history of stroke or cerebrovascular disease, and typically presents with **focal neurological deficits**. - **Parkinsonism** and **visual hallucinations** are not typical primary features of vascular dementia; cognitive decline is usually related to specific brain lesions. *Frontotemporal dementia* - **Frontotemporal dementia (FTD)** typically presents with prominent early changes in **behavior** (e.g., disinhibition, apathy) or **language difficulties**, rather than primary memory loss. - **Parkinsonism** and **visual hallucinations** are not characteristic features of FTD and would make this diagnosis less likely.
Explanation: ***Lewy body dementia***- The combination of **fluctuating cognition** (confusion, agitation, falling asleep during conversations), recurrent, well-formed **visual hallucinations**, and spontaneous **parkinsonism** (shuffling gait, mild tremor) is the classic diagnostic triad for Lewy body dementia.- It is characterized by the accumulation of **alpha-synuclein** protein deposits (Lewy bodies) in neurons, affecting both cognitive and motor functions.*Alzheimer's disease*- Typically presents with **insidious onset** of **progressive memory impairment** as the predominant symptom, rather than prominent fluctuations or early hallucinations.- Motor symptoms like parkinsonism appear very late, if at all, and are not core diagnostic features of early Alzheimer's.*Vascular dementia*- Cognitive decline often occurs in a **stepwise** fashion, frequently associated with a history of **cerebral vascular events** (strokes) or risk factors.- While gait disturbance is common, florid visual hallucinations and dramatic cognitive fluctuations are not typical or primary features of pure vascular dementia.*Frontotemporal dementia*- Primarily involves early changes in **personality**, **behavior** (e.g., disinhibition, apathy), or **language deficits**, often with executive dysfunction.- Lacks the characteristic combination of prominent visual hallucinations, rapid cognitive fluctuations, and parkinsonism seen in this patient.*Delirium*- Delirium is an **acute** and usually reversible disturbance in attention and consciousness, often triggered by underlying medical illness, infection, or medication.- While fluctuations and agitation are present, the patient's history describes chronic, progressive features consistent with a **dementia syndrome**, not an acute confusional state.
Explanation: ***Frontotemporal dementia*** - The clinical presentation of **progressive memory loss** and prominent **behavioral changes** over 8 months, coupled with specific **frontotemporal atrophy** on MRI, is highly characteristic of frontotemporal dementia. - This condition is characterized by early and prominent changes in personality, behavior, or language, often preceding significant memory deficits, which aligns with the described behavioral changes. *Alzheimer's disease* - While memory loss is a primary feature, Alzheimer's typically presents with **medial temporal lobe atrophy** (e.g., hippocampus) rather than predominantly frontotemporal atrophy on MRI. - Behavioral changes usually emerge later in the course of Alzheimer's, whereas they are often a presenting and prominent symptom in frontotemporal dementia. *Vascular dementia* - This type of dementia often presents with a **step-wise cognitive decline** and is associated with cerebrovascular disease and focal neurological signs. - MRI would typically show evidence of **infarcts** or **ischemic changes**, not specific frontotemporal atrophy in isolation, making it less likely. *Lewy body dementia* - Key features include **fluctuating cognition**, **recurrent visual hallucinations**, and **parkinsonism**. - While memory loss and behavioral changes occur, the absence of these characteristic features and the specific finding of frontotemporal atrophy do not support this diagnosis. *Normal pressure hydrocephalus* - This condition presents with a classic triad of **gait disturbance**, **urinary incontinence**, and **dementia** (often executive dysfunction). - MRI would reveal **ventriculomegaly** with normal or mildly increased CSF pressure, not selective frontotemporal atrophy.
Explanation: ***CT head*** - Given the patient's age (78 years), confusion, falls, and cognitive decline (MMSE 18/30), an initial **CT head** is crucial to rapidly rule out **reversible causes** of dementia and acute structural pathologies. - It efficiently identifies conditions like **subdural hematoma**, **normal pressure hydrocephalus (NPH)**, or **mass lesions** (e.g., tumors, large strokes) that require urgent management and can present with cognitive symptoms and falls. *MRI brain* - While **MRI brain** provides superior resolution for detecting subtle structural changes, such as **vascular disease**, **small infarcts**, or **white matter lesions**, it is often reserved for a more detailed evaluation after initial screening. - It is less available, more time-consuming, and not the primary initial choice when urgent exclusion of acute, potentially life-threatening causes is paramount. *Lumbar puncture* - This invasive procedure is typically indicated for the investigation of **rapidly progressive dementia**, suspected **infectious causes** (e.g., neurosyphilis, chronic meningitis), or **inflammatory conditions**. - It is not a routine initial investigation for gradual cognitive decline unless there are specific clinical features suggestive of these conditions. *EEG* - **Electroencephalography (EEG)** assesses brain electrical activity and is primarily used to investigate **seizure disorders** (e.g., non-convulsive status epilepticus mimicking confusion) or specific types of dementia like **Creutzfeldt-Jakob disease (CJD)**. - It does not provide the structural information needed to identify lesions or hydrocephalus that can cause acute confusion and falls. *PET scan* - **Positron Emission Tomography (PET)** scans (e.g., FDG-PET or amyloid-PET) are specialized functional imaging modalities used later in the diagnostic process to help differentiate specific types of dementia (e.g., **Alzheimer’s disease** from **frontotemporal dementia**). - It is a costly, advanced investigation and is not appropriate as the initial screening tool for structural brain pathology or reversible causes of cognitive impairment.
Explanation: ***Anorexia nervosa***- The triad of significantly **low BMI** (<17.5 kg/m² indicating severe restriction), **amenorrhea** due to HPO axis suppression, and **lanugo hair** (a compensatory mechanism for body temperature regulation in starvation) is highly specific for anorexia nervosa.- The presence of excessive exercise alongside severe weight loss strongly indicates the behavioral pathology of this disorder, even with the patient's denial, which is common.*Hyperthyroidism*- Although hyperthyroidism causes weight loss, it is typically accompanied by symptoms like **tachycardia**, **tremors**, goiter, and heat intolerance, which are absent here.- Hyperthyroidism does not cause the development of **lanugo hair**, which is a sign of chronic severe malnutrition.*Depression*- Depression can cause weight change and sometimes secondary amenorrhea, but it lacks the specific combination of the **low BMI**, excessive exercise, and physiological signs of starvation like **lanugo hair**.- The focus on weight-related behaviors (excessive exercise) points primarily toward an **eating disorder** rather than an isolated mood disorder.*Celiac disease*- Celiac disease leads to weight loss primarily through **malabsorption**, often associated with GI symptoms like chronic diarrhea or abdominal pain.- It does not explain the behavioral feature of **excessive exercise** or the dermatological finding of **lanugo hair** due strictly to gluten intolerance.*Addison's disease*- Addison's disease causes weight loss and fatigue but is classically characterized by **hyperpigmentation** (primary adrenal insufficiency) and volume depletion.- It does not typically present with the specific severe **malnutrition** signs (BMI 16, lanugo hair) or the core psychopathology of restricted intake and **excessive exercise** seen in this patient.
Explanation: ***Frontotemporal dementia***- The combination of progressive **personality changes** and memory loss, particularly with **frontotemporal atrophy** on MRI, is highly characteristic of Frontotemporal Dementia (FTD).- CSF showing **elevated tau** but **normal amyloid-β** further supports FTD (specifically tauopathies), as low amyloid-β is typically seen in Alzheimer's disease.*Alzheimer's disease*- While memory loss is prominent, **personality changes** are usually not the initial or most prominent symptom in early Alzheimer's compared to FTD.- **CSF amyloid-β** is typically **low** in Alzheimer's disease due to its deposition in plaques, which contradicts the normal amyloid-β finding in this patient.*Lewy body dementia*- This condition presents with a classic triad of **fluctuating cognition**, **recurrent visual hallucinations**, and **parkinsonism**, none of which are described.- MRI in LBD typically shows less specific atrophy, and CSF markers alone are not usually sufficient for differentiation without the characteristic clinical features.*Vascular dementia*- Vascular dementia is characterized by a **step-wise decline** in cognitive function, often associated with stroke or cerebrovascular disease, not typically a progressive decline over 8 months with frontotemporal atrophy.- Imaging would show evidence of **infarcts** or **white matter lesions**, which are not mentioned.*Normal pressure hydrocephalus*- The classic triad for NPH includes **gait disturbance**, **urinary incontinence**, and **dementia**, with MRI showing **ventriculomegaly**.- The patient's presentation of prominent personality changes and frontotemporal atrophy does not align with NPH.
Explanation: ***Frontotemporal dementia*** - The combination of **progressive memory loss** along with significant **behavioral changes** (specifically **disinhibited behavior**), **difficulty with language**, and **frontotemporal atrophy** on MRI, is highly indicative of frontotemporal dementia (FTD). - FTD is characterized by early and prominent alterations in personality, behavior, and/or language, often preceding significant memory deficits, unlike Alzheimer's. *Alzheimer's disease* - While memory loss is a primary feature of Alzheimer's, it typically presents with early and predominant **episodic memory impairment** and often involves **hippocampal/medial temporal atrophy** first. - Severe social disinhibition and early language difficulties (non-amnestic presentation) are less typical initial features of AD compared to FTD, which directly affects these frontal and temporal functions. *Vascular dementia* - This diagnosis is characterized by a **stepwise decline** in cognitive function and is associated with evidence of **cerebrovascular disease** (e.g., infarcts, white matter lesions) on imaging. - The case description does not mention a stepwise decline or history of strokes, nor does the MRI show classic vascular lesions but rather frontotemporal atrophy. *Lewy body dementia* - Key features of Lewy body dementia (LBD) include **fluctuating cognition**, recurrent detailed **visual hallucinations**, and spontaneous **parkinsonism**. - While behavioral changes and cognitive deficits occur, the specific presentation of prominent language difficulty and disinhibition, without the classic LBD triad, makes it less likely. *Normal pressure hydrocephalus* - Normal pressure hydrocephalus (NPH) is characterized by the classic triad of **gait disturbance**, **urinary incontinence**, and dementia. - MRI in NPH typically shows **ventriculomegaly** disproportionate to sulcal atrophy, not focal frontotemporal cortical atrophy as described in the patient's MRI.
Get full access to all questions, explanations, and performance tracking.
Start For Free